DiaSorin is an Italian multinational Group and a global leader in the market for in vitro diagnostics. DiaSorin is listed on the MTA (automated stock market) in the FTSE Italia Mid Cap Index, organized and managed by Borsa Italiana S.p.A
For over 40 years the Group has been developing, producing and commercializing diagnostic tests for a wide range of clinical areas. DiaSorin tests are designed for hospital and private testing laboratories, in the markets of immunodiagnostics and molecular diagnostics.
What make DiaSorin the Diagnostic Specialist?
It offers the broadest range of specialty tests available in the immunodiagnostics market
It continually invests in research and development, using its own distinctive expertise in the field of immunodiagnostics to deliver a high level of innovation
It provides complete and integrated solutions to meet the laboratory needs with flexibility
It is the exclusive supplier of the LIAISON® platform, a closed system based on a cutting-edge technology that is fully automated
Wide-ranging distribution system
It guarantees both direct and indirect global commercial presence
Its positive performance makes it possible to support a constant commitment to research and innovation, so that DiaSorin has an outstanding operating and financial track record